Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 949K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
3: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
10: R1 Document and Entity Information Document HTML 70K
11: R2 Condensed Consolidated Balance Sheets HTML 159K
12: R3 Condensed Consolidated Balance Sheet HTML 32K
(Parenthetical)
13: R4 Condensed Consolidated Statements of Operations HTML 118K
14: R5 Condensed Consolidated Statements of Comprehensive HTML 67K
Income
15: R6 Condensed Consolidated Statements of Changes in HTML 107K
Equity
16: R7 Condensed Consolidated Statement of Changes in HTML 18K
Equity (Parenthetical)
17: R8 Condensed Consolidated Statements of Cash Flows HTML 104K
18: R9 Basis of Presentation (Notes) HTML 19K
19: R10 Investments (Notes) HTML 131K
20: R11 Fair Value (Notes) HTML 89K
21: R12 Medical Costs Payable (Notes) HTML 31K
22: R13 Short-Term Borrowings and Long-Term Debt (Notes) HTML 26K
23: R14 Dividends (Notes) HTML 27K
24: R15 Commitments and Contingencies (Notes) HTML 24K
25: R16 Segment Financial Information (Notes) HTML 209K
26: R17 Basis of Presentation (Policies) HTML 23K
27: R18 Investments (Policies) HTML 18K
28: R19 Investments (Tables) HTML 131K
29: R20 Fair Value (Tables) HTML 90K
30: R21 Medical Costs Payable (Tables) HTML 31K
31: R22 Short-Term Borrowings and Long-Term Debt (Tables) HTML 25K
32: R23 Dividends (Tables) HTML 22K
33: R24 Segment Financial Information (Tables) HTML 206K
34: R25 Basis of Presentation (Details) HTML 17K
35: R26 Investments (Narrative) (Details) HTML 25K
36: R27 Investments (Short-Term and Long-Term Investments) HTML 68K
(Details)
37: R28 Investments (Amortized Cost and Fair Value of HTML 86K
Available-for-Sale Debt Securities by Contractual
Maturity) (Details)
38: R29 Investments (Fair Value of Available-For-Sale HTML 52K
Investments with Gross Unrealized Losses by
Investment Type and Length of Time That Individual
Securities Have Been in a Continuous Unrealized
Loss Position) (Details)
39: R30 Fair Value (Narrative) (Details) HTML 23K
40: R31 Fair Value (Financial Assets and Liabilities HTML 73K
Measured at Fair Value on a Recurring Basis)
(Details)
41: R32 Fair Value (Financial Assets and Liabilities, Not HTML 39K
Measured at Fair Value on a Recurring Basis)
(Details)
42: R33 Medical Costs Payable (Narrative) (Details) HTML 18K
43: R34 Medical Costs Payable (Details) HTML 38K
44: R35 Short-Term Borrowings and Long-Term Debt (Details) HTML 34K
45: R36 Dividends (Details) HTML 20K
46: R37 Commitments and Contingencies Narrative (Details) HTML 19K
47: R38 Segment Financial Information (Narrative) HTML 18K
(Details)
48: R39 Segment Financial Information (Details) HTML 125K
50: XML IDEA XML File -- Filing Summary XML 91K
9: XML XBRL Instance -- unh-20210630_htm XML 2.44M
49: EXCEL IDEA Workbook of Financial Reports XLSX 59K
5: EX-101.CAL XBRL Calculations -- unh-20210630_cal XML 173K
6: EX-101.DEF XBRL Definitions -- unh-20210630_def XML 405K
7: EX-101.LAB XBRL Labels -- unh-20210630_lab XML 988K
8: EX-101.PRE XBRL Presentations -- unh-20210630_pre XML 633K
4: EX-101.SCH XBRL Schema -- unh-20210630 XSD 79K
51: JSON XBRL Instance as JSON Data -- MetaLinks 307± 430K
52: ZIP XBRL Zipped Folder -- 0000731766-21-000037-xbrl Zip 267K
1.I have reviewed this report on Form 10-Q of UnitedHealth Group Incorporated (the “registrant”);
2.Based on my knowledge, this report does not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting
that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
1.I have reviewed this report on Form 10-Q of UnitedHealth Group Incorporated (the “registrant”);
2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors
and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
